You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API pantoprazole sodium delayed-release


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing pantoprazole sodium delayed-release

Company Ingredient NDC Excipient
Preferred Pharmaceuticals Inc pantoprazole sodium delayed-release 68788-8542 AMMONIA
Preferred Pharmaceuticals Inc pantoprazole sodium delayed-release 68788-8542 BUTYL ALCOHOL
Preferred Pharmaceuticals Inc pantoprazole sodium delayed-release 68788-8542 CALCIUM STEARATE
Preferred Pharmaceuticals Inc pantoprazole sodium delayed-release 68788-8542 CROSPOVIDONE
Preferred Pharmaceuticals Inc pantoprazole sodium delayed-release 68788-8542 FERRIC OXIDE RED
Preferred Pharmaceuticals Inc pantoprazole sodium delayed-release 68788-8542 FERROSOFERRIC OXIDE
Preferred Pharmaceuticals Inc pantoprazole sodium delayed-release 68788-8542 HYPROMELLOSE 2910
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for pantoprazole sodium delayed-release

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM STEARATE

Excipient focus: CROSPOVIDONE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: MANNITOL

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CARBONATE

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group